×
About 4,528 results

ALLMedicine™ Japanese Encephalitis Center

Research & Reviews  2,227 results

Monoclonal Antibody That Inhibits Cleavage Activity of Japanese Encephalitis Virus NS3.
https://doi.org/10.1089/mab.2020.0038
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy; Kai Y, Lilan X et. al.

Feb 24th, 2021 - Flavivirus protease has been deemed a potential target for drug and therapeutics development due to its crucial role in viral replication. In this study we prepared a monoclonal antibody (mAb) against nonstructural protein 3 (NS3) protease portion...

Estimating the health impact of vaccination against ten pathogens in 98 low-income and ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846814
Lancet (London, England); Li X, Mukandavire C et. al.

Jan 31st, 2021 - The past two decades have seen expansion of childhood vaccination programmes in low-income and middle-income countries (LMICs). We quantify the health impact of these programmes by estimating the deaths and disability-adjusted life-years (DALYs) a...

Inhibition of Japanese encephalitis virus proliferation by long non-coding RNA SUSAJ1 i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841041
Virology Journal; Zhou X, Yuan Q et. al.

Jan 29th, 2021 - Japanese encephalitis virus is a mosquito-borne neurotropic flavivirus that causes acute viral encephalitis in humans. Pigs are crucial amplifier host of JEV. Recently, increasing evidence has shown that long non-coding RNAs (lncRNAs) play importa...

Relevance of oxidative stress in inhibition of eIF2 alpha phosphorylation and stress gr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861526
PLoS Neglected Tropical Diseases; Blázquez AB, Martín-Acebes MA et. al.

Jan 25th, 2021 - Usutu virus (USUV) is an African mosquito-borne flavivirus closely related to West Nile, Japanese encephalitis, Zika, and dengue viruses. USUV emerged in 1996 in Europe, where quickly spread across the continent causing a considerable number of bi...

DHA attenuated Japanese Encephalitis virus infection-induced neuroinflammation and neur...
https://doi.org/10.1016/j.bbi.2021.01.012
Brain, Behavior, and Immunity; Chang CY, Wu CC et. al.

Jan 24th, 2021 - Japanese Encephalitis Virus (JEV) is a neurotropic virus and its Central Nervous System (CNS) infection causes fatal encephalitis with high mortality and morbidity. Microglial activation and consequences of bystander damage appear to be the domina...

see more →

Guidelines  4 results

Use of Japanese encephalitis vaccine in children: recommendations of the advisory commi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585349
MMWR. Morbidity and Mortality Weekly Report;

Nov 14th, 2013 - On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to includ...

Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunizati...
https://www.ncbi.nlm.nih.gov/pubmed/20224546
MMWR. Recommendations and Reports : Morbidity and Mortali... Fischer M, Lindsey N et. al.

Mar 12th, 2010 - This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC. Inactivated Japanese encephalitis virus vaccine: recommendations...

IXIARO (Japanese Encephalitis Vaccine, Inactivated, Adsorbed) Prescribing Information
https://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm142569.pdf

Adults older than 65 years of age: Primary immunization with IXIARO consists of two (2) 0.5 mL doses, administered 28 days apart. Complete the primary immunization series at least 1 week prior to potential exposure to JEV.

A case of probable Parkinson's disease after SARS-CoV-2 infection
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30305-7/fulltext
The Lancet Neurology; Cohen ME, Eichel R et. al.

Parkinson's disease or parkinsonism have been described after infections by viruses, such as influenza A, Epstein-Barr virus, varicella zoster, hepatitis C virus, HIV, Japanese encephalitis virus, or West Nile virus.We report a patient with probab...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  2,251 results

Monoclonal Antibody That Inhibits Cleavage Activity of Japanese Encephalitis Virus NS3.
https://doi.org/10.1089/mab.2020.0038
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy; Kai Y, Lilan X et. al.

Feb 24th, 2021 - Flavivirus protease has been deemed a potential target for drug and therapeutics development due to its crucial role in viral replication. In this study we prepared a monoclonal antibody (mAb) against nonstructural protein 3 (NS3) protease portion...

Estimating the health impact of vaccination against ten pathogens in 98 low-income and ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846814
Lancet (London, England); Li X, Mukandavire C et. al.

Jan 31st, 2021 - The past two decades have seen expansion of childhood vaccination programmes in low-income and middle-income countries (LMICs). We quantify the health impact of these programmes by estimating the deaths and disability-adjusted life-years (DALYs) a...

Inhibition of Japanese encephalitis virus proliferation by long non-coding RNA SUSAJ1 i...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841041
Virology Journal; Zhou X, Yuan Q et. al.

Jan 29th, 2021 - Japanese encephalitis virus is a mosquito-borne neurotropic flavivirus that causes acute viral encephalitis in humans. Pigs are crucial amplifier host of JEV. Recently, increasing evidence has shown that long non-coding RNAs (lncRNAs) play importa...

Relevance of oxidative stress in inhibition of eIF2 alpha phosphorylation and stress gr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861526
PLoS Neglected Tropical Diseases; Blázquez AB, Martín-Acebes MA et. al.

Jan 25th, 2021 - Usutu virus (USUV) is an African mosquito-borne flavivirus closely related to West Nile, Japanese encephalitis, Zika, and dengue viruses. USUV emerged in 1996 in Europe, where quickly spread across the continent causing a considerable number of bi...

DHA attenuated Japanese Encephalitis virus infection-induced neuroinflammation and neur...
https://doi.org/10.1016/j.bbi.2021.01.012
Brain, Behavior, and Immunity; Chang CY, Wu CC et. al.

Jan 24th, 2021 - Japanese Encephalitis Virus (JEV) is a neurotropic virus and its Central Nervous System (CNS) infection causes fatal encephalitis with high mortality and morbidity. Microglial activation and consequences of bystander damage appear to be the domina...

see more →

News  43 results

ACIP unanimously supports updates to Japanese encephalitis vaccination
https://www.mdedge.com/familymedicine/article/195352/vaccines/acip-unanimously-supports-updates-japanese-encephalitis?channel=39313
MDedge Infectious Disease; Heidi Splete

Feb 28th, 2019 - Vaccination against Japanese encephalitis is recommended for persons moving to endemic areas, or who travel to these areas frequently or for long-term visits, according to a vote at a meeting of the Centers for Disease Control and Prevention’s Adv.

Cost is high for Japanese encephalitis vaccinations
https://www.mdedge.com/internalmedicine/article/169654/international-id/cost-high-japanese-encephalitis-vaccinations
Ian Lacy

Jul 6th, 2018 - Vaccination costs surrounding Japanese encephalitis is high, according to an economic analysis presented at a meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices. copyright itsmejust/Thinkstock.

Clinical Trends for October 2017
https://reference.medscape.com/viewarticle/885717

Oct 26th, 2017 - Each week, we identify one top search term, speculate as to what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, feel free to share them with us on Twitter or Facebook! ...

Zika vaccine development expected to last through 2020
https://www.mdedge.com/dermatology/article/132153/vaccines/zika-vaccine-development-expected-last-through-2020
Deepak Chitnis

Feb 24th, 2017 - Progress continues to be made on creating a Zika vaccine, but taking any of the current candidates all the way through clinical trials and into production could take another few years, according to the latest information presented at a meeting of.

see more →